Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,37710,1522,1.14 [1.01-1.28],0.0363607618376226
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,37127,353,1.38 [1.11-1.72],0.0040337563946366
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,41134,277,1.16 [0.88-1.51],0.2907259685245389
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,28434,1278,1.28 [1.13-1.45],0.0001439146148049
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41043,186,1.17 [0.84-1.62],0.3654536760981449
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,38485,140,1.21 [0.84-1.76],0.3018286483341637
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43106,184,1.15 [0.82-1.61],0.4149953799582168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43110,124,0.67 [0.37-1.23],0.1988593290835093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,37600,95,1.29 [0.84-1.98],0.2502552613494198
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,41780,197,1.18 [0.86-1.63],0.30385887205305
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,41707,124,1.22 [0.83-1.80],0.3002754260212058
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43233,118,0.95 [0.58-1.55],0.840218954313975
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43239,143,1.44 [1.10-1.89],0.008026904692702
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43230,134,1.47 [1.12-1.93],0.0052998753578385
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,42681,93,1.14 [0.71-1.83],0.598773251636525
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",41216,683,1.13 [0.94-1.35],0.1955217555962212
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,40769,236,1.24 [0.94-1.63],0.130781962582376
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,41003,470,1.09 [0.87-1.37],0.4355799479189834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",34663,107,1.22 [0.79-1.87],0.3689116915658214
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34646,90,1.04 [0.63-1.72],0.8823846612319316
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",34999,443,0.99 [0.77-1.27],0.9552447968075596
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",35012,456,1.00 [0.79-1.28],0.977080984847097
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19658,569,1.15 [0.96-1.38],0.13192311297375
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15656,189,0.94 [0.62-1.44],0.7838056793525834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34646,90,0.90 [0.50-1.62],0.7212870155551556
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,38705,1304,1.23 [1.10-1.39],0.0005389632387562
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",41072,569,1.12 [0.91-1.36],0.2799222603861743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,42435,205,1.12 [0.81-1.56],0.4848962496428458
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43373,192,1.22 [0.89-1.67],0.211146128122233
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,42907,117,1.16 [0.76-1.77],0.4899401833604777
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43383,113,1.05 [0.65-1.68],0.8495055435104947
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Stomach,43464,83,1.24 [0.78-1.97],0.3606019831766321
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,43003,505,1.14 [0.93-1.39],0.2171287585830867
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43390,192,1.13 [0.82-1.57],0.4537371821029228
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43397,151,1.10 [0.75-1.62],0.6185547903747552
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43298,89,1.22 [0.78-1.89],0.3819235204147054
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",43303,88,1.23 [0.80-1.91],0.3413039328133251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,43147,336,1.05 [0.81-1.36],0.7003059523548629
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,43412,152,1.10 [0.77-1.57],0.6098196255223625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,43222,301,0.85 [0.61-1.19],0.3413587601783318
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of breast,23464,116,1.25 [0.88-1.77],0.2167192125460945
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Leiomyoma of uterus,23049,854,1.12 [0.96-1.31],0.153660405729182
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,41342,321,1.13 [0.88-1.46],0.3484814863976426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,40810,566,1.23 [1.03-1.46],0.0214737267824847
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,40810,566,1.23 [1.03-1.46],0.0214737267824847
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),37653,745,1.29 [1.10-1.51],0.0018673495541662
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42527,121,0.86 [0.51-1.43],0.5558438638876784
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,42958,137,1.59 [1.25-2.02],0.0001838772051973
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,35173,1908,1.14 [1.01-1.28],0.0355381552352287
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,40932,904,1.33 [1.16-1.51],2.1724859387844688e-05
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,39542,199,1.43 [1.10-1.86],0.0083311218697775
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41464,189,1.24 [0.88-1.74],0.2200142177952914
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39522,179,1.51 [1.17-1.97],0.0018414703588841
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,40249,906,1.15 [0.96-1.37],0.1325521177585202
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,40223,880,1.15 [0.96-1.37],0.1288509534854082
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,40258,299,1.25 [0.91-1.71],0.1742183382692754
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",40260,295,1.27 [0.93-1.74],0.1368097894763528
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,34881,1616,1.03 [0.90-1.19],0.6593231263681221
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",33476,211,1.01 [0.69-1.48],0.970891308304748
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,34759,1494,1.04 [0.90-1.20],0.6023920650297503
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,33352,87,1.57 [1.12-2.19],0.0079727725849411
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",33397,132,1.60 [1.22-2.09],0.000684745410191
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,36808,1086,1.18 [1.03-1.37],0.0195583390505211
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",36116,394,0.94 [0.69-1.27],0.6758769587847624
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",42780,288,0.99 [0.71-1.38],0.9455541191976352
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",42888,211,1.06 [0.73-1.54],0.7585933857951097
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,40454,101,0.92 [0.52-1.62],0.7673792074883993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",43302,101,0.90 [0.51-1.61],0.7267070293917548
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",35823,101,0.93 [0.53-1.64],0.8092260311410869
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Alcohol dependence,40475,122,1.13 [0.72-1.79],0.5970061297331678
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,40386,106,1.03 [0.60-1.74],0.9257574387034734
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35820,98,1.26 [0.82-1.92],0.2864237734089542
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",36247,525,1.18 [0.97-1.43],0.1025290633692815
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression,40765,458,1.16 [0.93-1.43],0.1799374583074828
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression or dysthymia,35848,399,1.11 [0.88-1.41],0.3843496148207135
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",35933,211,1.24 [0.93-1.64],0.1452788140347229
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Other anxiety disorders,40997,110,1.02 [0.62-1.66],0.9515979821390416
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,37384,2490,1.12 [1.01-1.23],0.0278122479549317
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,33979,239,1.39 [1.11-1.73],0.003552202810738
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43205,189,1.34 [1.04-1.73],0.0229522584811175
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,41250,806,1.18 [1.00-1.38],0.0480073960506511
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,40700,256,1.03 [0.75-1.41],0.8753487391731815
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,40579,135,1.01 [0.66-1.54],0.978364222345106
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",42958,120,1.07 [0.70-1.63],0.749130361878658
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42097,130,1.40 [1.01-1.95],0.0428401479187762
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,40720,276,1.28 [0.98-1.67],0.0679856926909761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,42511,211,1.34 [1.00-1.80],0.0495120906343171
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",41485,1109,1.00 [0.85-1.17],0.9728269478355688
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40581,205,1.01 [0.71-1.44],0.9654875980730993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41011,635,0.97 [0.79-1.21],0.8151920366695172
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,42977,138,1.06 [0.70-1.60],0.7937151876196311
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,42936,97,1.05 [0.64-1.74],0.844422555594494
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,42639,200,1.08 [0.77-1.52],0.6434303535018512
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42342,631,1.04 [0.86-1.27],0.6780195456189874
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42073,362,0.98 [0.74-1.29],0.871139696697081
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41839,128,1.07 [0.71-1.62],0.7508944054100261
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41910,199,0.82 [0.53-1.25],0.346602380237776
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41841,130,1.33 [0.95-1.86],0.1004868831104586
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,37444,265,1.06 [0.77-1.46],0.7302934414944628
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,37850,671,1.09 [0.89-1.32],0.4176417763540538
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,41766,342,0.95 [0.70-1.27],0.7110878851577591
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,42894,70,1.37 [0.84-2.25],0.2070832906340753
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3674,70,1.22 [0.72-2.08],0.4531319113370692
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",39290,70,1.41 [0.86-2.30],0.172192787302077
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,42324,158,1.17 [0.82-1.68],0.3829664725375222
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42250,84,0.98 [0.55-1.75],0.933455441460432
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",42293,138,0.89 [0.56-1.43],0.6352614598967448
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42549,167,0.66 [0.39-1.12],0.1233032111621861
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,43280,224,1.10 [0.80-1.51],0.5634372102298036
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,42038,182,1.28 [0.96-1.72],0.097355382854051
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,30723,5414,1.19 [1.09-1.29],3.5616564685457064e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,42416,116,1.25 [0.85-1.83],0.2557083980315371
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",32408,3710,1.20 [1.10-1.31],6.529733490755517e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,32451,3753,1.21 [1.11-1.32],3.267016811251759e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28794,96,1.83 [1.39-2.40],1.2448087866725172e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",39772,1960,1.17 [1.04-1.32],0.0079186350003557
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,38980,1168,1.11 [0.95-1.29],0.2065892535225491
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41687,384,1.07 [0.82-1.40],0.6063473543113174
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42080,777,1.14 [0.95-1.36],0.165168663441145
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43232,161,1.01 [0.66-1.55],0.9568698072819832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38303,491,1.26 [1.02-1.55],0.0324323112339839
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,39321,1541,1.16 [1.02-1.33],0.0288161810155952
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42052,189,1.15 [0.82-1.62],0.4108903051320917
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42258,396,1.14 [0.90-1.45],0.2636522151005762
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42031,168,1.04 [0.70-1.54],0.8395864538065981
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42032,169,1.04 [0.71-1.54],0.8321992149587267
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28860,162,1.09 [0.75-1.60],0.6519680864641113
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36141,97,1.49 [1.03-2.15],0.0355314476681211
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,36243,199,1.20 [0.86-1.67],0.2922838367136846
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24047,194,1.21 [0.88-1.67],0.2467419497657832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,24579,726,1.26 [1.05-1.52],0.0136651911627061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,36160,116,1.41 [0.99-2.02],0.0568981925281524
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,36201,157,1.04 [0.68-1.58],0.8584362775629879
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",41696,347,1.30 [1.02-1.65],0.0330833031641026
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",41969,255,0.94 [0.67-1.33],0.7329311548790802
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42027,216,0.87 [0.58-1.30],0.5061967989084707
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42155,188,0.81 [0.52-1.28],0.3696817056900428
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41455,128,1.12 [0.73-1.72],0.6087014029193092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,41549,222,1.21 [0.89-1.65],0.2198837976930574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41000,244,1.11 [0.82-1.52],0.4906326706485672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,40961,205,1.16 [0.84-1.60],0.365957378710978
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43087,197,1.18 [0.85-1.63],0.3273677991032724
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,41557,801,1.11 [0.95-1.31],0.1947283608719195
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,41497,136,1.02 [0.65-1.58],0.9466912656948896
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,34718,3516,1.17 [1.08-1.28],0.000129790857031
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43138,186,1.27 [0.95-1.69],0.1115846659529242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,40370,385,1.40 [1.15-1.69],0.0006094192443902
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",40322,337,1.41 [1.16-1.73],0.0006721782110591
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,41895,438,1.00 [0.78-1.29],0.9980469779739316
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,41888,431,0.96 [0.74-1.25],0.7710790814585292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42064,1030,1.02 [0.87-1.20],0.8014647888198889
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,41197,163,0.98 [0.65-1.47],0.9090899483625956
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,41243,209,0.85 [0.57-1.28],0.4339722835544833
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41689,655,1.05 [0.87-1.28],0.6029130660418495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,41342,308,0.99 [0.74-1.33],0.9378516118235114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20000,104,1.37 [0.92-2.02],0.1174611509779362
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,38792,1726,1.14 [1.01-1.28],0.0283862038546814
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,41482,298,1.05 [0.76-1.44],0.7814790443073194
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",41524,340,1.09 [0.82-1.45],0.5601021149655363
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",41524,340,1.09 [0.82-1.45],0.5601021149655363
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",40498,1416,1.09 [0.96-1.25],0.1718822191889167
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Asthma,31042,1416,1.12 [0.98-1.27],0.0851716106530797
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",30597,1416,1.12 [0.99-1.28],0.0761075162543894
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",31022,1396,1.12 [0.98-1.28],0.0840754653032287
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,42817,175,1.73 [1.39-2.14],5.850402184136002e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,40899,136,1.70 [1.32-2.20],4.304712396221648e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",42949,136,1.69 [1.31-2.17],4.906148932089055e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,40887,124,1.71 [1.31-2.24],8.968490296681188e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,39957,185,1.41 [1.07-1.85],0.0132154439668148
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,40177,405,1.32 [1.08-1.62],0.0061125998494819
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,41317,188,1.20 [0.86-1.66],0.282910926252048
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,29629,9820,1.11 [1.04-1.18],0.0009648170090111
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42576,716,1.11 [0.94-1.32],0.2159899124376861
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43404,151,1.01 [0.69-1.49],0.9472111722780924
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,43410,140,1.06 [0.73-1.56],0.7512161982645292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,42052,192,1.26 [0.94-1.68],0.1300265621093343
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42036,176,1.04 [0.72-1.51],0.8235716520749017
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43387,169,1.01 [0.70-1.46],0.9657363381566492
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42018,158,0.71 [0.42-1.19],0.1928299524835571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41585,138,1.23 [0.86-1.76],0.2484794843659823
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43272,95,1.32 [0.89-1.96],0.1609502860753631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33124,457,1.15 [0.92-1.44],0.2237041241980276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",36329,3662,1.13 [1.04-1.23],0.0032972948745872
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,33244,577,1.17 [0.96-1.42],0.1120064235012698
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,33859,1192,1.16 [1.01-1.33],0.0392700668561496
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,32801,134,0.82 [0.48-1.38],0.4484215672080743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33027,360,1.05 [0.80-1.38],0.7236505798406196
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32762,95,0.86 [0.47-1.58],0.6255929319200948
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,32916,249,1.21 [0.90-1.61],0.2013175040127612
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,32884,217,1.15 [0.82-1.59],0.4177454456297278
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43243,156,0.88 [0.55-1.41],0.6002598628860779
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,32881,214,1.00 [0.70-1.45],0.9877266086497384
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),34038,1371,1.10 [0.96-1.26],0.1814992623966691
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,43194,221,0.88 [0.61-1.28],0.5099520657145091
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,33400,733,1.22 [1.04-1.43],0.012692427709627
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,32958,291,0.82 [0.57-1.17],0.2658217427521449
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43178,265,1.15 [0.87-1.52],0.3165526813098035
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,43151,178,0.80 [0.51-1.25],0.3361800939881186
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,38100,2747,1.06 [0.95-1.17],0.2898923531245247
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,36364,1011,0.91 [0.76-1.10],0.3263881442587286
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,35560,207,1.12 [0.79-1.59],0.521527997858765
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,35517,164,1.11 [0.76-1.62],0.5803563712373015
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,36825,1472,1.11 [0.97-1.26],0.1312220425256829
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,41821,1295,1.11 [0.97-1.26],0.1197574128565946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,34082,3372,1.07 [0.98-1.17],0.1167649692275292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42896,99,1.29 [0.89-1.87],0.1841043813363385
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",43352,135,1.17 [0.81-1.68],0.3987137645101325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,40661,135,1.17 [0.82-1.68],0.3876522701533152
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40627,101,1.34 [0.94-1.90],0.1055854399586315
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",43230,230,1.13 [0.83-1.52],0.4394468650459432
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,40756,230,1.13 [0.84-1.53],0.4197599078553372
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40730,204,1.19 [0.88-1.60],0.2714092733617962
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41586,1060,1.07 [0.92-1.24],0.3664360896070683
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41574,1048,1.08 [0.93-1.25],0.3343050659461598
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,30880,170,0.98 [0.66-1.46],0.9285614089864732
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal stricture,42679,170,0.99 [0.66-1.48],0.9499817770615838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",30824,114,1.00 [0.62-1.61],0.9936236911606476
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,31715,1005,1.11 [0.95-1.30],0.1737969660687186
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,30993,283,1.05 [0.79-1.40],0.7180219934934519
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,31185,475,1.17 [0.95-1.43],0.1335784262448612
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,40760,430,1.17 [0.95-1.44],0.149186171023667
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,42702,152,1.00 [0.67-1.51],0.9852824903878316
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30953,243,1.14 [0.86-1.53],0.3598999656942924
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30833,123,0.99 [0.62-1.58],0.964832826475322
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32201,1491,1.07 [0.94-1.22],0.2874815546914077
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,31168,458,1.06 [0.84-1.34],0.6074532319941577
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,42679,129,0.98 [0.63-1.54],0.9396029065623548
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,42077,207,1.21 [0.89-1.65],0.2293067662298776
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,41986,116,1.30 [0.89-1.90],0.1752607421492207
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",41125,1032,1.26 [1.11-1.44],0.0004546901497541
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,40919,826,1.30 [1.13-1.49],0.0003263970293796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,40256,163,1.16 [0.82-1.65],0.4022618356520645
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40172,79,0.89 [0.47-1.66],0.706574735587991
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,40200,107,1.36 [0.94-1.97],0.1039292998745242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),43159,107,1.35 [0.93-1.96],0.1143233404125809
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,41111,528,1.30 [1.09-1.54],0.0036326185794093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40702,119,1.48 [1.12-1.95],0.0060959452039503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,40682,99,1.48 [1.10-2.00],0.0104113011246211
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40667,84,1.44 [0.99-2.10],0.0589309342424128
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,40919,336,1.14 [0.88-1.47],0.3095987705976251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,40909,326,1.14 [0.88-1.48],0.3222129769409642
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,38183,2641,1.13 [1.03-1.24],0.0134346686241597
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,42698,188,0.98 [0.66-1.45],0.9193529198545556
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42771,775,1.06 [0.89-1.26],0.5147133741701955
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,40800,969,1.03 [0.87-1.21],0.7255902421676077
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,41919,680,1.20 [1.01-1.43],0.0348801659793963
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41393,154,1.20 [0.84-1.70],0.3211778206889503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,41667,428,1.23 [0.99-1.52],0.0622656559979213
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,42978,155,1.30 [0.94-1.79],0.1149910511050242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,42942,119,1.39 [0.99-1.95],0.0571535254081878
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42915,92,1.40 [0.95-2.05],0.0848059680337793
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42094,98,0.80 [0.43-1.48],0.484157417999261
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42611,615,1.11 [0.92-1.34],0.2911344796748654
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,39987,156,0.71 [0.42-1.20],0.2029159117389978
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39995,164,0.72 [0.44-1.19],0.2002125723833283
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39958,127,0.57 [0.30-1.08],0.0854152301550019
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40206,375,1.05 [0.81-1.35],0.7263186304222704
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40171,340,1.10 [0.85-1.42],0.4704994169383669
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,31300,6730,1.13 [1.05-1.21],0.0005925504925448
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,34024,3918,1.14 [1.05-1.24],0.00121388869157
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,39164,2059,1.03 [0.91-1.15],0.6584537110281938
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30364,258,1.49 [1.23-1.80],5.442679680840845e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,30877,771,1.35 [1.17-1.55],3.040337908032993e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",42742,247,1.52 [1.25-1.85],2.4577021336872795e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,42759,223,1.59 [1.31-1.93],3.065432258790789e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,32028,1922,1.15 [1.03-1.29],0.0132681933424202
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",36390,1922,1.14 [1.01-1.27],0.0281542956140048
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30227,121,1.37 [0.92-2.03],0.1221508481079213
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",42521,117,1.37 [0.93-2.04],0.1145036156093405
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,30459,353,1.12 [0.87-1.44],0.3927772705216811
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,30224,118,1.64 [1.26-2.15],0.0002797702419691
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,30587,481,1.28 [1.05-1.54],0.0120622151626242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43172,245,1.39 [1.09-1.77],0.0072357352260273
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,30993,887,1.01 [0.84-1.21],0.9184957823141208
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,30746,640,1.24 [1.04-1.47],0.0147641065003992
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,32294,2188,1.07 [0.96-1.19],0.2144776182857916
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30224,118,0.96 [0.59-1.55],0.8558672967697283
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30506,400,1.13 [0.91-1.40],0.2726519510620602
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30193,87,0.91 [0.50-1.64],0.7452556875632022
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30207,101,1.42 [1.04-1.94],0.0295260238661403
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,30914,808,1.02 [0.85-1.22],0.8597813395582672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,30803,697,0.89 [0.71-1.10],0.2686842471291023
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,33632,475,1.27 [1.05-1.55],0.0152924999630974
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42491,242,1.33 [1.05-1.69],0.0163956058072312
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42343,94,1.71 [1.31-2.24],8.355036949375113e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,37603,111,1.21 [0.81-1.80],0.3547665876521445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,38006,514,1.19 [0.97-1.45],0.0933048153173654
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,39074,1582,1.17 [1.04-1.31],0.0075970617106381
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,37821,329,1.29 [1.03-1.62],0.0273123482624181
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,37636,144,1.03 [0.67-1.59],0.894126580669365
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",38741,1249,1.17 [1.03-1.33],0.0139417890549218
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37578,86,0.97 [0.55-1.72],0.92019384414795
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,37895,403,1.13 [0.90-1.42],0.2866951817264584
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37663,171,0.93 [0.61-1.40],0.7143888048758056
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37622,130,1.06 [0.69-1.63],0.7799556143751236
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,37722,230,1.30 [1.01-1.67],0.0414378190805863
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37602,110,1.15 [0.76-1.76],0.511444055427424
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38020,528,1.24 [1.04-1.49],0.0186856107280697
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37637,532,0.95 [0.75-1.20],0.6652194199363424
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37219,114,0.94 [0.56-1.56],0.8061757377573897
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37255,150,0.95 [0.60-1.48],0.8041748345571631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37278,173,0.71 [0.43-1.16],0.1705556437893074
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37192,87,1.14 [0.70-1.84],0.6024715618005267
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37305,200,1.10 [0.79-1.55],0.5677913972987535
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37283,178,1.10 [0.77-1.58],0.5864425106175566
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37541,436,0.89 [0.68-1.18],0.4183977615148122
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37200,95,0.58 [0.28-1.22],0.1490869963253472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37230,125,1.06 [0.67-1.67],0.7966744464089894
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37316,211,0.91 [0.62-1.33],0.6185851344430613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37212,107,0.82 [0.46-1.46],0.4988254937451032
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",37869,764,1.11 [0.93-1.32],0.2385947256880486
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37395,290,1.11 [0.84-1.46],0.4792228058353457
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37514,409,1.19 [0.95-1.48],0.1265471448767892
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,40258,286,1.24 [0.97-1.59],0.0871581810914824
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,40615,643,1.13 [0.94-1.36],0.1820592649733224
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40048,76,1.24 [0.77-1.99],0.3705942698278063
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40064,92,0.72 [0.37-1.40],0.3284677806390254
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40138,166,0.81 [0.51-1.29],0.3698793467109789
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,34612,7163,1.16 [1.09-1.24],2.9938871390654967e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17193,1051,1.14 [0.97-1.33],0.1058303501527165
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,39260,364,1.62 [1.37-1.92],1.4216556967035445e-08
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39003,107,1.32 [0.89-1.95],0.1718182084141336
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,39490,77,1.68 [1.18-2.41],0.0043554333476105
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,39494,81,2.21 [1.78-2.76],1.543134280452526e-12
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39508,95,1.88 [1.45-2.45],2.168723284416007e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42843,399,1.08 [0.84-1.38],0.5510490618584285
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,42741,111,1.55 [1.14-2.09],0.0048778911756418
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42730,286,0.99 [0.73-1.36],0.961206266478523
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42585,141,1.11 [0.74-1.65],0.6258495409750182
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,39780,1749,1.05 [0.93-1.19],0.3923796586618369
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,38186,155,0.94 [0.60-1.46],0.7765891238670596
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38161,130,1.22 [0.83-1.78],0.3089581777799099
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,38477,446,1.11 [0.88-1.39],0.3974368396739126
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38224,193,1.07 [0.75-1.53],0.7245528231708347
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,39180,1149,1.12 [0.98-1.29],0.0991308789177663
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16613,471,1.05 [0.82-1.34],0.7062017725904397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16229,87,0.83 [0.43-1.59],0.5722340273870241
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,16230,88,1.79 [1.31-2.45],0.0002898256160034
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16274,132,1.10 [0.71-1.69],0.6756324960567855
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16274,132,1.14 [0.75-1.75],0.5403154593807251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16313,171,1.22 [0.87-1.72],0.2519982188321789
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23254,417,1.01 [0.79-1.28],0.9574949639640692
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22969,132,1.16 [0.81-1.67],0.4193906890910462
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22977,140,0.91 [0.58-1.43],0.6838507853469962
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22940,103,1.13 [0.73-1.75],0.5762447106905717
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23198,474,1.00 [0.79-1.25],0.965824169983402
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22838,114,0.95 [0.59-1.54],0.8429310372101757
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22935,211,1.09 [0.80-1.47],0.5827012067554462
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21445,3934,1.17 [1.08-1.26],0.0001214800705793
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,17811,300,1.24 [1.00-1.55],0.0512925049911592
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17595,84,1.17 [0.77-1.79],0.4596816277323368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17650,139,1.21 [0.87-1.68],0.2552210771573043
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18191,680,1.16 [0.97-1.38],0.095698592983171
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17857,346,1.16 [0.92-1.45],0.2043121544842401
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18327,816,1.18 [1.02-1.37],0.0288981946692965
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17780,269,1.11 [0.84-1.46],0.4570688721343672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17884,373,1.20 [0.97-1.49],0.0935942406383831
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17595,84,0.92 [0.52-1.63],0.7702345059382559
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17673,162,1.27 [0.95-1.69],0.1026345974413767
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23486,225,1.28 [1.01-1.63],0.043251345590293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23495,214,1.26 [0.98-1.62],0.06796670670969
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23516,120,1.01 [0.65-1.56],0.9586504451850856
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23508,131,1.08 [0.73-1.59],0.7076272381720714
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17634,123,1.43 [1.08-1.90],0.013037570746391
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17614,103,0.98 [0.59-1.63],0.945709303874218
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17631,120,1.16 [0.78-1.71],0.459334884406179
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Irregular menses,23427,405,1.19 [0.98-1.46],0.080532682933648
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18668,1157,1.23 [1.08-1.39],0.0014093231552722
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18267,756,1.22 [1.05-1.42],0.0085742894825426
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23501,175,1.38 [1.09-1.76],0.0084664048046093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17911,400,1.05 [0.83-1.32],0.7013020184217802
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17782,271,1.28 [1.04-1.59],0.0229794518269368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18287,776,1.14 [0.96-1.35],0.1344645476205923
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female infertility,17596,85,1.03 [0.61-1.72],0.9168006744938636
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17589,78,1.07 [0.64-1.78],0.7919887698547498
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23511,713,0.88 [0.71-1.09],0.2386173129079538
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23517,975,0.80 [0.65-0.98],0.0336579529517907
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23509,378,0.89 [0.67-1.18],0.4142243861416126
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23239,108,0.90 [0.54-1.50],0.6980589898721056
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23285,154,0.68 [0.40-1.16],0.157116009708308
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23264,133,1.23 [0.88-1.71],0.21893882736908
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23526,135,1.01 [0.67-1.54],0.946006369996891
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23528,133,1.00 [0.65-1.53],0.9893394030590892
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23526,345,1.09 [0.85-1.41],0.483805443263047
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23284,103,1.09 [0.69-1.73],0.711420187216599
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23373,192,1.08 [0.77-1.52],0.6681670894034655
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22915,117,0.97 [0.61-1.55],0.9094138314636552
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22965,167,0.77 [0.48-1.24],0.2846276466006313
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22995,197,0.74 [0.47-1.16],0.1876052525317166
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22918,120,0.98 [0.63-1.53],0.9221769867615224
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22910,112,1.18 [0.82-1.69],0.3663085449759198
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22920,122,0.84 [0.50-1.39],0.4894644793043835
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22727,185,0.76 [0.48-1.19],0.2287415416516425
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22898,356,0.72 [0.51-1.01],0.0596557342055976
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23087,545,0.94 [0.75-1.19],0.6071538858788003
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23532,141,0.74 [0.43-1.25],0.2572014057878014
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22340,107,0.51 [0.25-1.06],0.0707362757904061
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22624,82,1.10 [0.69-1.74],0.6876109441393836
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23537,279,0.68 [0.46-1.01],0.0574406554383356
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23474,216,0.69 [0.44-1.08],0.1079706831108912
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23526,207,0.95 [0.66-1.37],0.7960558621185077
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23516,197,0.90 [0.61-1.33],0.5967871074190605
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",42808,99,0.89 [0.50-1.61],0.7080799983171393
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,39244,1003,1.05 [0.90-1.23],0.552535974057992
